The 19-hospital system also reported a 66.7 percent increase in net income for the 12 months ended Dec. 31, 2021, from $1.3 billion in 2020 to $2.2 billion in 2021.
Cleveland Clinic’s total unrestricted revenue was $12.4 billion in 2021, compared to $10.6 billion in 2020. This is largely attributable to net patient service revenue, which was nearly $11 billion in 2021 and $9.1 billion in 2020.
The system’s total expenses were nearly $11 billion in 2021, a 13.6 percent increase from 2020, which saw expenses hit nearly $9.7 billion. Salaries, wages and benefits accounted for $6.7 billion of the system’s expenses, up from $5.9 billion in 2020.
For the three months ended Dec. 31, 2021, Cleveland Clinic’s net income fell 58.2 percent, from $1.3 billion in 2020 to $532.8 million in 2021.
Its revenues reached $3.3 billion for the fourth quarter of 2021, a 12.3 percent increase from 2020 at about $3 billion. Fourth quarter expenses were $3 billion, up from $2.5 billion in 2020.
Cleveland Clinic’s operating income was $196.8 million in the fourth quarter of 2021, a 42.2 percent decrease from the $340.2 million recorded in the same period in 2020.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
